Management of gout in a South Auckland general practice

Journal of Primary Health Care

Volumn 6, Issue 1, 2014, Pages 73-78

  Reaves, Esther ^a   Arroll, Bruce ^b  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Allopurinol; Cardiovascular diseases; Gout; Primary health care; Uric acid

Indexed keywords

URIC ACID;

CLINICAL PRACTICE; ETHNOLOGY; GENERAL PRACTICE; GOUT; HUMAN; NEW ZEALAND; OCEANIC ANCESTRY GROUP; URINE;

GENERAL PRACTICE; GOUT; HUMANS; NEW ZEALAND; OCEANIC ANCESTRY GROUP; PHYSICIAN'S PRACTICE PATTERNS; URIC ACID;

EID: 84897591299     PISSN: 11726164     EISSN: 11726156     Source Type: Journal    
DOI: 10.1071/hc14073     Document Type: Article

References (28)

1. Doherty M. New insights into the epidemiology of gout. Rheumatology. 2009;48(Suppl 2):ii2-ii8.
2. Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis. 2008;67(7):960-6.
3. Roddy E, Zhang W, Doherty M. Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations. Ann Rheum Dis. 2007;66(10):1311-5.
4. Pal B, Foxall M, Dysart T, Carey F, Whittaker M. How is gout managed in primary care? A review of current practice and proposed guidelines. Clin Rheumatol. 2000;19(1):21-5.
5. Arroll B, Bennett M, Dalbeth N, Hettiarachchi D, Ben C, Shelling G. More allopurinol is needed to get gout patients < 0.36 mmol/l: a gout audit in the form of a before-after trial. J Prim Health Care. 2009;1(4):315-8.
6. Klemp P, Stansfield SA, Castle B, Robertson MC. Gout is on the increase in New Zealand. Ann Rheum Dis. 1997;56(1):22-6.
7. Winnard D, Wright C, Taylor WJ, Jackson G, Te Karu L, Gow PJ, et al. National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology.2012;51(5):901-9.
8. Martini N, Bryant L, Te Karu L, Aho L, Chan R, Miao J, et al. Living with gout in New Zealand: an exploratory study into people's knowledge about the disease and its treatment. J Clin Rheumatol. 2012;18(3):125-9.
9. Keming W, Jackson G. The changing demography of Counties Manukau District Health Board. Counties Manukau District Health Board; 2008.
10. Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2006;65(10):1312-24.
11. Fravel MA, Ernst ME. Management of gout in the older adult. Am J Geriatr Pharmacother. 2011;9(5):271-85.
12. Dalbeth N, Gow P. Prevention of colchicine toxicity in patients with gout. N Z Med J. 2007;120(1252):U2503.
13. Winnard D, Kake T, Gow P, Barratt-Boyes C, Harris V, Hall DA, et al. Debunking the myths to provide 21st century management of gout. N Z Med J. 2008;121(1274):79-85.
14. Lindsay K, Gow P, Vanderpyl J, Logo P, Dalbeth N. The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. J Clin Rheumatol. 2011;17(1):1-6.
15. Rider TG, Jordan KM. The modern management of gout. Rheumatology. 2010;49(1):5-14.
16. O'Reilly S, Doherty M. Missed opportunity following diagnosis of gout. Ann Rheum Dis. 1995;54(2):86-7.
17. Colvine K, Kerr AJ, McLachlan A, Gow P, Kumar S, Ly J, et al. Cardiovascular disease risk factor assessment and management in gout: an analysis using guideline-based electronic clinical decision support. N Z Med J. 2008;121(1285):73-81.
18. Salmond C, Crampton P, King P, Waldegrave C. NZiDep: a New Zealand index of socioeconomic deprivation for individuals. Soc Sci Med. 2006;62(6):1474-85.
19. New Zealand Guidelines Group. New Zealand Cardiovascular Guidelines Handbook: A summary resource for primary care practitioners. 2nd ed. Wellington: New Zealand Guidelines Group; 2009.
20. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-47.
21. Dore RK. The gout diagnosis. Cleve Clin J Med. 2008;75(Suppl 5):S17-21.
22. Sarawate CA, Patel PA, Schumacher HR, Yang W, Brewer KK, Bakst AW. Serum urate levels and gout flares: analysis from managed care data. J Clin Rheumatol. 2006;12(2):61-5.
23. Logan JA, Morrison E, McGill PE. Serum uric acid in acute gout. Ann Rheum Dis. 1997;56(11):696-97.
24. Ministry of Health. Korero marama: health literacy and Maori results from the 2006 Adult Literacy and Life Skills Survey. Wellington,: Ministry of Health; 2010.
25. Aubert RE. Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization: a randomized, controlled trial. Ann Intern Med. 1998;129(8):605.
26. Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006;54(8):2688-96.
27. Janssens HJ, van de Lisdonk EH, Bor H, van den Hoogen HJ, Janssen M. Gout, just a nasty event or a cardiovascular signal? A study from primary care. Fam Pract. 2003;20(4):413-6.
28. Wilson A, Childs S. The relationship between consultation length, process and outcomes in general practice: a systematic review. Br J Gen Pract. 2002;52(485):1012-20.